Athira Pharma Inc. (ATHA): Price and Financial Metrics
GET POWR RATINGS... FREE!
ATHA Stock Price Chart Interactive Chart >
ATHA Price/Volume Stats
| Current price | $4.04 | 52-week high | $14.22 |
| Prev. close | $3.89 | 52-week low | $2.53 |
| Day low | $3.90 | Volume | 198,687 |
| Day high | $4.10 | Avg. volume | 454,749 |
| 50-day MA | $3.32 | Dividend yield | N/A |
| 200-day MA | $4.74 | Market Cap | 152.83M |
Athira Pharma Inc. (ATHA) Company Bio
Athira Pharma, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company was founded by Leen Kawas and Joseph Harding in 2011 and is headquartered in Seattle, WA.
Latest ATHA News From Around the Web
Below are the latest news stories about ATHIRA PHARMA INC that investors may wish to consider to help them evaluate ATHA as an investment opportunity.
Former Athira CEO on her controversial exit: 'I was relieved that it came to an end'Leen Kawas resigned as Athira's CEO in October 2021 after an investigation into her doctoral work. She's now forging a new path with a life sciences investment firm and telling her side of the story. |
Athira Pharma Provides 2023 Pipeline OutlookAdvancing small molecule therapeutic candidates with clinical and preclinical data suggesting potential neuroprotective, neurotrophic, procognitive and disease-modifying effects Fosgonimeton Phase 2/3 LIFT-AD study in mild-to-moderate Alzheimer’s disease is progressing with targeted enrollment completion in mid-2023 and topline data in early 2024 ATH-1105 candidate for amyotrophic lateral sclerosis (ALS) is targeted for IND filing in 2023 BOTHELL, Wash., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Athira |
Wall Street Starts 2023 On Positive NoteU.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.65% to 33,361.96 while the NASDAQ rose 1.38% to 10,610.40. The S&P 500 also rose, gaining, 0.95% to 3,875.90. Check This Out: 4 Penny Stocks Insiders Are Buying: Athira Pharma, Great Elm Group And More Leading and Lagging Sectors Energy shares gained by 0.5% on Tuesday. Meanwhile, top gainers in the sector included Ecopetrol S.A. (NYSE: EC ), up 6%, and Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT ), up 5%. In trading on Tuesday, materials shares fell 1%. Top Headline US manufacturing PMI fell to 46.2 for December, versus prior reading of 47.7. Analysts were also expecting a reading of 46.2. Equities Trading UP ReShape Life... |
4 Penny Stocks Insiders Are Buying: Athira Pharma, Great Elm Group And MoreUS stocks recorded losses for 2022. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company''s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga''s insider transactions platform. BitNile Holdings The Trade: BitNile Holdings, Inc. (NYSE: NILE ) Executive Chairman Milton C. Ault III bought a total of 1,913,777 shares at an average price of $0.10. To acquire these shares, it cost around $197.12 thousand. What’s Happening: BitNile Holdings plans to launch a next-generation marketplace, BitNile.com... |
Athira Pharma Inc. (NASDAQ: ATHA) Jumps 1.93%: The Most Likely Path Going ForwardAthira Pharma Inc. (NASDAQ:ATHA) shares, rose in value on Friday, 12/30/22, with the stock price up by 1.93% to the previous day’s close as strong demand from buyers drove the stock to $3.17. Actively observing the price movement in the last trading, the stock closed the session at $3.11, falling within a range of $3.06 … Athira Pharma Inc. (NASDAQ: ATHA) Jumps 1.93%: The Most Likely Path Going Forward Read More » |
ATHA Price Returns
| 1-mo | 27.44% |
| 3-mo | 32.03% |
| 6-mo | 11.60% |
| 1-year | -60.78% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 27.44% |
| 2022 | -75.67% |
| 2021 | -61.96% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...